Newsbenzinga
Recursion Announces Sanofi Option Of First Immunology Drug Candidate, Triggering $10M Milestone Payment And Potential Phase 1 Trials In 2027
· Published
Article summary
Please check the source for details.
An excerpt from the original article.
Comments —
Loading comments…